The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Tindamax
tinidazole · TINIDAZOLE 500 mg/1 · Tablet, Film Coated · Oral · Mission Pharmacal Company
NDC 00178-8500-20 · 20 TABLET, FILM COATED in 1 BOTTLE · NDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Part D plans paid (avg)$3.07per dosage unitgross, before rebates — matched by drug name · 2024
- Medicaid generic ceiling (FUL)$2.56per TABweighted avg manufacturer price $0.6120 · Apr 1, 2019
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
Estimated fill cost
Estimated WAC per estimate
≈ $13.417
No Texas or California filing exists for this NDC — this figure is derived, not filed.
This is an ESTIMATE derived from NADAC, not a filed or published price: pharmacies typically acquire brand drugs at roughly 2–4% below list, so list ≈ NADAC ÷ 0.97. Shown only because no state transparency filing exists for this NDC.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for tinidazole (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Mikart, LLCUnited Statesmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA021618
- TE code
- AB
- Approval date
- May 17, 2004
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of tinidazole (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| BioComp Pharma, Inc. | TINIDAZOLE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | TINIDAZOLE 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | TINIDAZOLE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mission Pharmacal Company | TINIDAZOLE 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mission Pharmacal Company | TINIDAZOLE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Remedyrepack Inc. | TINIDAZOLE 500 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | TINIDAZOLE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | TINIDAZOLE 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Tindamax — NDC 00178-8500-20," retrieved September 3, 2026, https://drugdashboards.com/drug/00178850020.
Free to cite with attribution — see how the data is put together.